BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24128676)

  • 1. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
    Siman R; Lin YG; Malthankar-Phatak G; Dong Y
    J Neuropathol Exp Neurol; 2013 Nov; 72(11):1062-71. PubMed ID: 24128676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
    Siman R; Cocca R; Dong Y
    PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propagation of tau pathology in a model of early Alzheimer's disease.
    de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
    Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits.
    Harris JA; Koyama A; Maeda S; Ho K; Devidze N; Dubal DB; Yu GQ; Masliah E; Mucke L
    PLoS One; 2012; 7(9):e45881. PubMed ID: 23029293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.
    Ramirez JJ; Poulton WE; Knelson E; Barton C; King MA; Klein RL
    Behav Brain Res; 2011 Jan; 216(1):332-40. PubMed ID: 20727915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
    García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
    Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
    Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
    Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-synaptic spread of tau pathology in vivo.
    Liu L; Drouet V; Wu JW; Witter MP; Small SA; Clelland C; Duff K
    PLoS One; 2012; 7(2):e31302. PubMed ID: 22312444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
    Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
    J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
    Pooler AM; Polydoro M; Wegmann SK; Pitstick R; Kay KR; Sanchez L; Carlson GA; Gomez-Isla T; Albers MW; Spires-Jones TL; Hyman BT
    J Comp Neurol; 2013 Dec; 521(18):4236-48. PubMed ID: 23839581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats.
    Mustroph ML; King MA; Klein RL; Ramirez JJ
    Behav Brain Res; 2012 Jul; 233(1):141-8. PubMed ID: 22561128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
    Maurin H; Chong SA; Kraev I; Davies H; Kremer A; Seymour CM; Lechat B; Jaworski T; Borghgraef P; Devijver H; Callewaert G; Stewart MG; Van Leuven F
    PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
    Hochgräfe K; Sydow A; Mandelkow EM
    FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
    J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
    Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
    J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.